logo
  • genedrive.com
  • About us
    • Company profile
    • Board of Directors
    • Advisors
    • Modern Slavery Statement
    • Net Zero Statement
    • Code of Conduct
    • Carbon Reduction Plan
  • Our product
  • News & Events
    • Press releases
    • Events
  • Careers
    • Careers
    • Applicants Privacy Notice
  • Investor relations
    • AIM Rule 26
    • Investor relations
    • Shareholders
    • Share price information
    • Regulatory news
    • Reports & presentations
    • Analyst notes
    • Constitutional documents
    • Investor news
    • Corporate governance
    • Investor contacts
    • Company information

Shareholders

Home > Investor relations > Shareholders

Identity and percentage holding of significant shareholders
 

Substantial holdings Shares held %
     
     
Directors and related shareholders  
Russ Shaw 2,700,000 0.43%
Ian Gilham 2,505,961 0.4%
Gino Miele 2,202,187 0.35%
Tom Lindsay 1,151,605 0.18%
Chris Yates 267,554 0.04%
Total Directors' holdings 8,827,307 1.41%
     
Total shares in issue 624,895,408 100.00%

 

Shareholder information

genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.

Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.

Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 624,895,408.

Number of AIM securities not in public hands is 8,827,307 or 1.41%.

Text updated:  27/04/2025

Latest reports

share price graph

05 December 2024

Annual Report and Accounts 2024

View all reports >

Investor News

Tuesday May 13, 2025

Genedrive test kits set for new NHS trial in Manchester

Tuesday August 06, 2024

genedrive shares down 10% after CEO departure

Friday August 02, 2024

Small-cap Movers: UK Oil & Gas lights up on innovative hydrogen pans

View all news >

BIVDA-stamp-2023
  • Privacy
  • Terms of use
  • Site map

© 2017-25 genedrive plc

genedrive plcThis site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this againclose